Condition
Crohn's Disease Aggravated
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Withdrawn1
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02997059Phase 2CompletedPrimary
Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease.
NCT04100005Withdrawn
A Pilot Study to Explore the Role of Gut Flora in Crohn's Disease
NCT05463900Unknown
Microbial and Human Determinants of the Onset of IBD Flares
Showing all 3 trials